UMB Bank
RLAY icon

UMB Bank’s Relay Therapeutics RLAY Stock Holding History

UMB Bank’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$13.3K Hold
735
– – ﹤0.01% 1814
2026
Q2 		$13.8K Hold
735
– – ﹤0.01% 1830
2026
Q1 		$7.31K Hold
735
– – ﹤0.01% 1953
2025
Q4 		$6.22K Hold
735
– – ﹤0.01% 1964
2025
Q3 		$3.84K Buy
+735
New +$2.8K ﹤0.01% 1943

Other funds holding RLAY

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Zweig-DiMenna Associates
Zweig-DiMenna Associates New York $1.3B AUM 120.13% 1-Year Est. Return

UMB Bank's RLAY Position: Q3 2026 in Review

UMB Bank held its Relay Therapeutics (RLAY) position steady in Q3 2026 at 735 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1814.

UMB Bank first reported a position in RLAY in Q3 2025 and has held it in 5 quarters since. The position peaked at $13.8K in Q2 2026. 84 funds tracked by Wall St. Rank hold RLAY as of Q3 2026.

  • UMB Bank held 735 shares of Relay Therapeutics worth $13.3K as of Q3 2026.
  • UMB Bank left its Relay Therapeutics share count unchanged in Q3 2026.
  • Relay Therapeutics made up ﹤0.01% of UMB Bank's portfolio in Q3 2026, its #1814 holding.
  • UMB Bank first reported a position in Relay Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • UMB Bank's Relay Therapeutics position peaked at $13.8K in Q2 2026.
  • 84 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2026.

Based on UMB Bank's 13F filing for Q3 2026, filed 6 Nov 2026.